Cargando…
Comorbidities impact and de-prescribing in elderly with HCV-related liver disease: analysis of a prospective cohort
Management for HCV has undergone a notable change using direct-acting antiviral drugs (DAAs), which are safe and effective even in elderly. Here, we define impact of comorbidities, concomitant medication and drug–drug interactions in elder patients with HCV related disease before starting DAAs regim...
Autores principales: | Licata, Anna, Minissale, Maria Giovanna, Giannitrapani, Lydia, Montalto, Filippo A., Lombardo, Clelia, Mirarchi, Luigi, Amodeo, Simona, Soresi, Maurizio, Montalto, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841322/ https://www.ncbi.nlm.nih.gov/pubmed/33909256 http://dx.doi.org/10.1007/s11739-021-02741-9 |
Ejemplares similares
-
The Changing Epidemiology of Hepatocellular Carcinoma : Experience of a Single Center
por: Giannitrapani, Lydia, et al.
Publicado: (2020) -
SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease
por: Mirarchi, Luigi, et al.
Publicado: (2022) -
COVID in 2022. Clinical risk management of sars-cov-2 positive patients admitted to an internal medicine ward
por: Licata, Anna, et al.
Publicado: (2022) -
Surveillance Program for Diagnosis of HCC in Liver Cirrhosis: Role of Ultrasound Echo Patterns
por: Soresi, Maurizio, et al.
Publicado: (2017) -
The Role of Vitamin Deficiency in Liver Disease: To Supplement or Not Supplement?
por: Licata, Anna, et al.
Publicado: (2021)